ONCE Cupón: Support for Eosinophilic Esophagitis (EoE) & Awareness | March 10th

Berlin, Germany – A dedicated lottery draw by ONCE, Spain’s national organization for the blind, is shining a light on eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus that often goes undiagnosed. The initiative, launching on March 10th, will feature five million lottery tickets emblazoned with the message “Una enfermedad invisible que necesita visibilidad” – “An invisible disease that needs visibility” – and will directly benefit the Asociación Española de Esofagitis Eosinofílica (AEDESEO), a patient advocacy group working to improve the lives of those affected by this challenging condition.

Eosinophilic esophagitis, or EoE, is characterized by a buildup of eosinophils – a type of white blood cell – in the esophagus, leading to inflammation and difficulty swallowing. While it can affect individuals of any age, We see increasingly recognized in both children and adults. The condition can significantly impact quality of life, causing discomfort, pain, and nutritional deficiencies. Understanding the complexities of EoE and increasing awareness are crucial steps toward earlier diagnosis and more effective management.

AEDESEO, founded in 2012, has quickly become a vital resource for patients and families navigating the challenges of EoE. The organization, recognized as being of public utility, was the first in Spain and Europe specifically dedicated to promoting diagnosis and providing support for individuals with this condition. Their operate extends beyond simply offering information; they provide a comprehensive network of support, including psychological, nutritional, speech therapy, and social work services, all aimed at improving the well-being of those living with EoE.

Understanding Eosinophilic Esophagitis: Symptoms and Diagnosis

The hallmark symptom of EoE is dysphagia, the medical term for difficulty swallowing. This can manifest in various ways, from a sensation of food getting stuck in the esophagus to chest pain or discomfort during meals. Patients often find themselves modifying their eating habits – chewing food more thoroughly, cutting it into smaller pieces, or drinking fluids to aid in swallowing – to cope with these challenges. In severe cases, food can become completely impacted, requiring medical intervention to dislodge it.

Diagnosing EoE requires a multi-faceted approach. According to the American College of Allergy, Asthma & Immunology, diagnosis typically involves an upper endoscopy, a procedure where a thin, flexible tube with a camera is inserted into the esophagus to visualize the lining. Biopsies are then taken to examine the number of eosinophils present. A concentration of 15 or more eosinophils per high-power field, or more than 60 eosinophils per square millimeter, is generally considered indicative of EoE. AEDESEO emphasizes the importance of this histological analysis in confirming a diagnosis.

The Role of AEDESEO: Support, Research, and Advocacy

AEDESEO’s commitment extends far beyond direct patient support. The organization actively works to advance research into the causes and potential cures for EoE. They advocate for increased funding for studies investigating the disease’s underlying mechanisms and the development of more effective treatments. Their website, www.aedeseo.es, serves as a central hub for information, resources, and a supportive community for patients, families, and healthcare professionals.

The organization’s impact is amplified by its network of delegations across Spain, including Madrid, Catalonia, Valencia, Murcia, Galicia, Andalusia, Castile-La Mancha, the Basque Country, and Navarre. These regional branches allow AEDESEO to provide localized support and connect with patients in their communities. AEDESEO also actively participates in scientific conferences and workshops, disseminating knowledge and fostering collaboration among healthcare professionals. They also offer a range of complementary therapies, including psychology, nutrition, speech therapy, and social work, to address the multifaceted needs of individuals with EoE.

The ONCE Lottery: Raising Awareness and Funds

The decision by ONCE to dedicate a lottery draw to EoE is a significant step toward raising awareness of this often-overlooked condition. ONCE, a social enterprise dedicated to people with visual impairments, regularly supports various causes through its lottery initiatives. The Cupón Diario, the daily lottery ticket, offers a top prize of €500,000, along with numerous other prizes totaling a substantial amount. The lottery tickets, sold by over 21,000 vendors across Spain, and also available online at www.juegosonce.es, provide a unique opportunity to support AEDESEO’s vital work while also participating in a chance to win.

The funds raised through this lottery draw will be instrumental in supporting AEDESEO’s ongoing initiatives, including research grants, patient support programs, and educational outreach efforts. The organization also provides information on the Spanish Registry of Clinical Studies (REec), a public database of clinical trials with medications, offering patients potential avenues for participation in cutting-edge research. AEDESEO also actively encourages donations through Bizum, using the code 09145, and highlights the potential for tax benefits on charitable contributions.

The Importance of Early Diagnosis and Management

Early diagnosis and appropriate management are critical for improving the long-term outcomes for individuals with EoE. While there is currently no cure for the condition, various treatment options are available to manage symptoms and prevent complications. These include dietary modifications, such as elimination diets to identify and avoid trigger foods, and medications, such as proton pump inhibitors and topical corticosteroids, to reduce inflammation. In some cases, esophageal dilation – a procedure to widen the esophagus – may be necessary to address strictures caused by chronic inflammation.

The increasing recognition of EoE as a distinct clinical entity has led to significant advances in our understanding of the disease and its management. Ongoing research is focused on identifying novel therapeutic targets and developing more personalized treatment approaches. Organizations like AEDESEO play a crucial role in advocating for patients, promoting research, and ensuring that individuals with EoE have access to the care and support they demand to live full and productive lives.

Key Takeaways

• Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus, often characterized by difficulty swallowing.
• AEDESEO is a Spanish patient advocacy group dedicated to supporting individuals and families affected by EoE.
• ONCE is dedicating a lottery draw to raise awareness and funds for AEDESEO, highlighting the need for greater visibility of this condition.
• Early diagnosis and appropriate management are crucial for improving the long-term outcomes for individuals with EoE.

The ONCE lottery draw supporting AEDESEO represents a powerful collaboration between a social enterprise and a patient advocacy group, demonstrating a shared commitment to raising awareness and improving the lives of those affected by eosinophilic esophagitis. Further updates on AEDESEO’s initiatives and research progress can be found on their website, www.aedeseo.es. We encourage readers to share this information and contribute to the conversation about EoE to help ensure that this “invisible disease” receives the attention and support it deserves.